UBS raises Covid-19 loss estimate to $30bn-$60bn on non-US BI fears
Analysts at UBS have raised their estimate of insured losses from the coronavirus pandemic to between $30bn and $60bn, from their previous range of $20bn to $40bn.
Analysts at UBS have raised their estimate of insured losses from the coronavirus pandemic to between $30bn and $60bn, from their previous range of $20bn to $40bn.